A South Korea study compared the incidence of some inflammatory rheumatic diseases during the COVID-19 pandemic (from a countrywide healthcare claims database) with data from the previous 4 years: the annual incidence of PMR (RR = 1.075; 95% CI: 0.928–1.239) exhibited an increasing trend, yet without reaching statistical significance [ 31 ].
← all excerpts
Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literature.
1
—
—